US 7846892
Compositions and methods for Alzheimer's disease
granted A61KA61K2039/505A61P
Quick answer
US patent 7846892 (Compositions and methods for Alzheimer's disease) held by Primex Clinical Laboratories, Inc. expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Primex Clinical Laboratories, Inc.
- Grant date
- Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61P, A61P25/28